Drug misuse: psychosocial interventions

Summary

NICE has produced two guidelines on drug misuse – ‘Drug misuse: psychosocial interventions’ (NICE clinical guideline 51) and ‘Drug misuse: opioid detoxification’ (NICE clinical guideline 52). They cover: 

• the support and treatment people can expect to be offered if they have a problem with or are dependent on opioids, stimulants or cannabis
• how families and carers may be able to support a person with a drug problem and get help for themselves.

NICE clinical guideline 51 makes recommendations for the use of psychosocial interventions in the treatment of people who misuse opioids, stimulants and cannabis in the healthcare and criminal justice systems.

NICE has produced a joint quick reference guide and ‘Understanding NICE guidance’ that cover both guidelines, as well as tools to help organisations implement this guidance – these have been integrated with tools for other NICE guidance on drug misuse.

Documents

For healthcare professionals

• CG51 Drug misuse: psychosocial interventions: NICE guideline
• CG51 Drug misuse: psychosocial interventions: NICE guideline (MS Word format)
• CG51 Drug misuse: psychosocial interventions: Full guideline
• CG51 Drug misuse: psychosocial interventions: Full guideline, appendices 14 -16
• CG51 Drug misuse: psychosocial interventions: Quick reference guide

For patients, carers and the public

• CG51 Drug misuse: psychosocial interventions and opioid detoxification: Understanding NICE guidance
• CG51 Drug misuse: psychosocial interventions and opioid detoxification: Understanding NICE guidance (MS Word format)

Background information

• 2007/038 NICE guidelines published to improve treatment for substance misuse

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• Drug misuse: psychosocial interventions and opioid detoxification: Costing report
• Drug misuse: psychosocial interventions and opioid detoxification: Costing template
• Misuse of drugs and other substances: Presenter slides
• Misuse of drugs and other substances: Audit criteria